NCCN Clinical Practice Guidelines in Oncology Updated to Recommend BESREMi (ropeginterferon alfa-2b-njft) as a Preferred Intervention for Polycythemia Vera

Press/Media

Period	23 May 2023

Media coverage

Title	NCCN Clinical Practice Guidelines in Oncology Updated to Recommend BESREMi (ropeginterferon alfa-2b-njft) as a Preferred Intervention for Polycythemia Vera
Media name/outlet	India Pharma News
Country/Territory	India
Date	23/05/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=689H-CXC1-DXMP-K1JR-00000-00
Persons	John Mascarenhas